Concurrent Use of Opioids and Benzodiazepines (CUOB, CMS Adult Core Set)

The percentage of Medicaid members age 18 and older with concurrent use of prescription opioids and benzodiazepines. Patients with a cancer diagnosis, sickle cell disease diagnosis,
or in hospice or palliative care are excluded.

Measure Identifier: CMS_A_CUOB

Please see Report Details below for more information on selected subgroups, organizations, and aggregation.

Tables

Data


LICENSE AGREEMENTS AND ACKNOWLEDGMENTS

Utilizing the Technical Specifications and Resource Manual and the Value Sets for the Adult and Child Core Set and data from this report indicates your agreement and acceptance of the following license agreements and acknowledgements.

The American Medical Association (AMA) and the American Hospital Association (AHA) permit the use of Current Procedural Terminology (CPT) and National Uniform Billing Committee (NUBC) UB-04 codes solely for the purpose of reporting state data on Medicaid and CHIP Core Set measures to the Centers for Medicare & Medicaid Services (CMS).


CMS Disclaimer

The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT should be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.


For Proprietary Codes in the Adult Core Set:

CPT ® codes, descriptions and other data only are copyright 2023 American Medical Association (AMA). All rights reserved. CPT is a trademark of the American Medical Association. No fee schedules, basic units, relative values or related listings are included in CPT. The AMA assumes no liability for the data contained or not contained herein. Applicable FARS/HHSARS restrictions apply to government use.

The Uniform Billing Codes (UB) are Copyright © 2023, the American Hospital Association (AHA), Chicago, Illinois. The UB Codes are included with the permission of the AHA. All uses of the UB Codes may require a license from the AHA. Specifically, anyone desiring to use the UB Codes in a commercial manner must obtain a commercial use license directly from the AHA. To inquire about licensing, contact ub04@aha.org.

Some measure specifications contain coding from LOINC ® (https://loinc.org). The LOINC table, LOINC codes, LOINC panels and form file, LOINC linguistic variants file, LOINC/RSNA Radiology Playbook, and LOINC/IEEE Medical Device Code Mapping Table are copyright © 1995–2023, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and available at no cost under the license at https://loinc.org/terms-of-use.

“SNOMED” and “SNOMED CT” are registered trademarks of the International Health Terminology Standards Development Organisation (IHTSDO).

“HL7” is the registered trademark of Health Level Seven International.


For the CMS Use of Pharmacotherapy for Opioid Use Disorder measure in the Adult Core Set:

The Use of Pharmacotherapy for Opioid Use Disorder (OUD) measure is maintained by The Lewin Group for Centers for Medicare & Medicaid Services (CMS) Programs through the Home and Community-Based Services (HCBS) Measures Development, Endorsement, Maintenance, and Alignment contract HHSM-500-2014-00033I, Task Order 75FCMC19F0004.


For Proprietary Codes:

Limited proprietary coding is contained in the measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. Lewin disclaims all liability for use or accuracy of any CPT or other codes contained in the specifications. Professional organizations frequently update their codes. Code lists for calculation of this measure were accurate as of October 2023.

The International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) is published by the World Health Organization (WHO). ICD-10-CM is an official Health Insurance Portability and Accountability Act standard.

Level II HCPCS codes in these specifications are approved and maintained jointly by the Alpha-Numeric Panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association.)

The National Drug Code (NDC) Directory is published by the U.S. Food and Drug Administration and ismade available under the Open Database License at https://opendatacommons.org/licenses/odbl/1.0/. Any rights in individual contents of the database are licensed under the Database Contents License at https://opendatacommons.org/licenses/dbcl/1-0/.


For the PQA measures in the Adult Core Set:

PQA, Inc. retains all rights of ownership to the PQA measure specifications and value sets and can rescind or alter the measures at any time. No use of any PQA measure is authorized without prior PQA approval of such use. All uses of PQA measures are subject to such conditions as PQA specifies, and certain uses of the measures may be subject to a licensing agreement specifying the terms of use and the licensing fee. Users of the measure shall not have the right to alter, enhance, or otherwise modify the measures.

By agreeing to this statement, user accepts the following limitations of the use of the PQA measures: User acknowledges that the PQA measure specifications and value sets will only be used for the sole purpose of reporting state data on Medicaid and CHIP Core Set measures to the Centers for Medicare & Medicaid Services (CMS) and will not be used for other purposes. Except for the purpose indicated above, the PQA measure specifications and value sets will not be used in any other commercial product, service, or value-added benefit. User also acknowledges that the PQA value sets will not be forwarded or provided to anyone outside of their organization.


For Codes in the Public Domain used in the Adult Core Set measures:

The International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) is published by the World Health Organization (WHO). ICD-10-CM is an official Health Insurance Portability and Accountability Act standard.

The International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) is published by the World Health Organization (WHO). ICD-10-PCS is an official Health Insurance Portability and Accountability Act standard.

The National Drug Code (NDC) Directory is published by the U.S. Food and Drug Administration and is made available under the Open Database License at https://opendatacommons.org/licenses/odbl/1-0/.

Any rights on individual contents of the database are licensed under the Database Contents License at https://opendatacommons.org/licenses/dbcl/1-0/.